Our founding partner Sandra Pohlman is honored with one of the most prestigious…
Sandra Pohlman
Partner
B.S. Biology
Sandra Pohlman is co-founder and partner of df-mp. She co-heads the firm’s large and diversified biotechnology and pharmaceuticals practice group. A main part of her practice is oppositions and prosecution before the European Patent Office, where she has consistently obtained favorable results for her clients. Ms. Pohlman is an experienced patent litigator and adviser in the life science patent field. She is qualified to practice before the European Patent Office as a legal practitioner, the Unified Patent Court (UPC) and the German courts. Additionally, she is a registered U.S. Patent Attorney.
+ 49 89 210 296 0
sandra.pohlman@df-mp.com
Sandra Pohlman
Partner
B.S. Biology
Sandra Pohlman is co-founder and partner of df-mp. She co-heads the firm’s large and diversified biotechnology and pharmaceuticals practice group. A main part of her practice is oppositions and prosecution before the European Patent Office, where she has consistently obtained favorable results for her clients. Ms. Pohlman is an experienced patent litigator and adviser in the life science patent field. She is qualified to practice before the European Patent Office as a legal practitioner, the Unified Patent Court (UPC) and the German courts. Additionally, she is a registered U.S. Patent Attorney.
+ 49 89 210 296 0
sandra.pohlman@df-mp.com
practice areas.
Ms. Pohlman advises international clients in the field of life science patents, with her particular focus in the areas of molecular biology, immunology, pharmaceutical agents and formulations, DNA/RNA based diagnostics, CRISPR, second medical uses and dosing regimens. A main part of her practice is oppositions and prosecution before the European Patent Office, where she has handled over 100 oppositions and hundreds of patent applications.
She has served as lead counsel in notable opposition cases relating to patents for blockbuster drugs and ground-breaking technologies including, more recently, Tecfidera®, Tysabri®, and attacking and defending CRISPR patents, as well as numerous antibody-related oppositions (adalimumab, herceptin, bevacizumab, pertuzumab, nivolumab, pembrolizumab). Ms. Pohlman handles prosecution in the pharmaceutical and biotechnology fields for more than three decades and can deliver complex portfolio strategies that add value.
Our firm is again recognised as a “leading firm” in…
We are pleased to be recommended again in the latest…
We are delighted to be listed again in this year’s…
Partner Sandra Pohlman is honored as one of the best…
Founding partner Sandra Pohlman is once again listed among the…
df-mp is proud to receive another five IP stars this…
Founding partner Sandra Pohlman is recommended in the Best-Lawyers-Ranking 2019…
df-mp is delighted that five partners have been awarded the…
admissions.
- Attorney at Law (Germany and USA)
- Registered before EPO as a legal practitioner
- Unified Patent Court (UPC) Representative
- Solicitor (England & Wales)
- U.S. Patent Attorney
- Admitted to the bar of Washington, DC, U.S.A
- Admitted to practice before the U.S. Court of Appeals for the Federal Circuit
AWARDS AND RECOMMENDATIONS.
In IAM 1000: The World's Leading Patent Practitioners 2013-2024, Ms. Pohlman was recommended for her expertise in patent prosecution and invalidity actions including the following comments about her skills: "She displays a matchless knowledge of her law, her writing is brilliant, and she is hugely responsive", and: "She can handle high-pressure briefs with a cool head and is the first choice for North American law firms".
Managing Intellectual Property lists Sandra Pohlman as IP Star for Germany in their MIP Handbook 2014-2024, and she is listed in Chambers 2021-2024, including in the Chambers Global Guide since 2024. She was listed as one of the Top 250 Women in IP (worldwide) by Managing IP in 2016-2024, and is a recognized Thought Leader-Germany-Intellectual Property in Who’s Who Legal.
In 2022, Managing IP awarded her the prize of Germany’s Attorney of the Year for Patents, and in 2024, her EPO team received the prestigious award for European Patent & Regulatory Team of the Year for the matter of Tecfidera versus generics.
In the press/podcasts:
- Sandra talks about her career path with Dayna Matthew, Dean of GW Law School, from where she graduated with high honors in 1994:
https://soundcloud.com/gwlaw/s5-ep-3-ip-law-abroad-with-sandra-pohlman?in=gwlaw/sets/testimony-gw-law-experts - Sandra provides advice on practical patenting tips in EPO’s Talk Innovation podcast series:
https://open.spotify.com/episode/2gJxaVMf7MyQ8fHZatLBig?si=KE_l7FmWROiWH6zWqxtjXQ - Women in IP Leadership article features Sandra’s career in patent law:
https://patentlawyermagazine.com/wp-content/uploads/2023/12/TPL69_interactive.pdf
curriculum vitae.
Since 2000
Co-founder and partner at df-mp
1997-1999
Associate at the firm of Bardehle, Pagenberg, Dost, Altenburg, Frohwitter, Geissler and subsequently at the Frohwitter firm, both in Munich, Germany
1992-1996
Law clerk and subsequently as associate for the intellectual property law firm of Finnegan, Henderson, Farabow, Garrett & Dunner (with a strong emphasis on litigation and prosecution of patents in the biotechnology and pharmaceutical area)
1991-1994
Jurist Doctor Degree (magna cum laude) from the National Law Center of the George Washington University in Washington, DC, U.S.A.
1987-1991
Bachelor of Science Degree in Biology (with high honors) from the University of Vermont, U.S.A.
association memberships.
YOUR PARTNER
For Patents. Trademarks. Designs.
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB © 2024 df-mp | Your partner for Patents. Trademarks. Designs. All Rights Reserved.
